Caitlin Kontulis - 17 Feb 2023 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Secretary & VP Finance & Admin
Signature
Caitlin Kontulis
Issuer symbol
PHIO
Transactions as of
17 Feb 2023
Net transactions value
$0
Form type
4
Filing time
22 Feb 2023, 18:05:19 UTC
Previous filing
17 Feb 2023
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Award $0 +4,500 +56% $0.000000 12,494 17 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments.
F2 Includes shares of common stock underlying unvested restricted stock units.